Park BK - Search Results

1

TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.

Alfirevic A, Vilar FJ, Alsbou M, Jawaid A, Thomson W, Ollier WE, Bowman CE, Delrieu O, Park BK, Pirmohamed M. Alfirevic A, et al. Among authors: park bk. Pharmacogenomics. 2009 Apr;10(4):531-40. doi: 10.2217/pgs.09.6. Pharmacogenomics. 2009. PMID: 19374512

2

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.

Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. Alfirevic A, et al. Among authors: park bk. Pharmacogenomics. 2006 Sep;7(6):813-8. doi: 10.2217/14622416.7.6.813. Pharmacogenomics. 2006. PMID: 16981842

3

Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.

Alfirevic A, Park BK, Pirmohamed M, Naisbitt DJ. Alfirevic A, et al. Among authors: park bk. Pharmacogenomics. 2012 Nov;13(14):1567-9. doi: 10.2217/pgs.12.146. Pharmacogenomics. 2012. PMID: 23148633 No abstract available.

4

TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.

Maher B, Alfirevic A, Vilar FJ, Wilkins EG, Park BK, Pirmohamed M. Maher B, et al. Among authors: park bk. AIDS. 2002 Oct 18;16(15):2013-8. doi: 10.1097/00002030-200210180-00005. AIDS. 2002. PMID: 12370499

5

Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.

Alfirevic A, Stalford AC, Vilar FJ, Wilkins EG, Park BK, Pirmohamed M. Alfirevic A, et al. Among authors: park bk. Br J Clin Pharmacol. 2003 Feb;55(2):158-65. doi: 10.1046/j.1365-2125.2003.01754.x. Br J Clin Pharmacol. 2003. PMID: 12580987 Free PMC article.

6

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity.

Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK, Pirmohamed M. Hughes DA, et al. Among authors: park bk. Pharmacogenetics. 2004 Jun;14(6):335-42. doi: 10.1097/00008571-200406000-00002. Pharmacogenetics. 2004. PMID: 15247625

7

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy.

Zhang JE, Jorgensen AL, Alfirevic A, Williamson PR, Toh CH, Park BK, Pirmohamed M. Zhang JE, et al. Among authors: park bk. Pharmacogenet Genomics. 2009 Oct;19(10):781-9. doi: 10.1097/FPC.0b013e3283311347. Pharmacogenet Genomics. 2009. PMID: 19741565

8

Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.

Owen A, Goldring C, Morgan P, Chadwick D, Park BK, Pirmohamed M. Owen A, et al. Among authors: park bk. Br J Clin Pharmacol. 2005 Mar;59(3):365-70. doi: 10.1111/j.1365-2125.2005.02229.x. Br J Clin Pharmacol. 2005. PMID: 15752383 Free PMC article.

9

Drug-specific T cells in an HIV-positive patient with nevirapine-induced hepatitis.

Drummond NS, Vilar FJ, Naisbitt DJ, Hanson A, Woods A, Park BK, Pirmohamed M. Drummond NS, et al. Among authors: park bk. Antivir Ther. 2006;11(3):393-5. Antivir Ther. 2006. PMID: 16759058

10

Immunological principles of T-cell-mediated adverse drug reactions in skin.

Naisbitt DJ, Pirmohamed M, Park BK. Naisbitt DJ, et al. Among authors: park bk. Expert Opin Drug Saf. 2007 Mar;6(2):109-24. doi: 10.1517/14740338.6.2.109. Expert Opin Drug Saf. 2007. PMID: 17367257 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,551 results

Search Page

Filters